Titan Medical Inc. Announces Receipt of Final Approval to Graduate to TSX
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 09/29/14 -- Titan Medical Inc. ("Titan" or the "Company")(TSX VENTURE: TMD) (OTCQX: TITXF) today announced that, effective at market opening on September 30, 2014, Titan's common shares and warrants will commence trading on the Toronto Stock Exchange ("TSX"). Concurrent with the TSX listing, the Company's common shares and warrants will be de-listed from the TSX Venture Exchange.
John Hargrove, Titan's Chairman and Chief Executive Officer, commented, "As the TSX is one of the world's leading stock exchanges, we are pleased to have achieved this milestone. The TSX Venture Exchange has served us extremely well as the platform for the first phase of our capital markets strategy. We believe that our listing on the senior stock exchange will enhance our company's visibility and will provide increased access to capital markets and a more diverse investor base."
The trading symbols and CUSIP / ISIN numbers for Titan's common shares and listed warrants will remain unchanged.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's Single Port Orifice Robotic Technology, SPORT™ Surgical System, currently under development, is comprised of a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT™ Surgical System is being designed to expand robotic surgery into both simple and complex areas of surgical specialties and procedures that are currently under-serviced. It is also being designed to allow surgeons to perform procedures within small- to medium-size surgical spaces, such as general surgery and cholecystectomy. For more information, visit the Company's website at .
Forward-Looking Statements
This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors " section of the Company's Annual Information Form dated April 4, 2014 (which may be viewed at ). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Titan Medical Inc.
John Hargrove
Chairman and Chief Executive Officer
(416) 548-7522 (ext. 151)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.09.2014 - 11:00 Uhr
Sprache: Deutsch
News-ID 339497
Anzahl Zeichen: 0
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 231 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Titan Medical Inc. Announces Receipt of Final Approval to Graduate to TSX"
steht unter der journalistisch-redaktionellen Verantwortung von
Titan Medical Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
